Ultrasound-guided caudal quadratus lumborum block combined with the greater ischiatic notch plane block as motor-protective analgesia for the pelvic limb in dogs.

OBJECTIVE: To develop an ultrasound-guided caudal quadratus lumborum block (C-QLB) technique in canine cadavers and to compare sensory and motor blockade resulting from the combination of ultrasound-guided greater ischiatic notch (GIN) plane and C-QLB approaches (GIN-CQLB group) versus a lumbosacral plexus (LSP group) approach [combination of lateral pre-iliac (LPI) and parasacral (PS) techniques] in dogs. STUDY DESIGN: Descriptive anatomical study and prospective randomized, blinded, experimental crossover trial. ANIMALS: A total of six canine cadavers and six adult Beagle dogs. METHODS: Phase I: following ultrasound-guided C-QLB injections of 0.3 mL kg-1 of dye, using the interfascial plane located lateral to the quadratus lumborum muscle at the level of the sixth lumbar vertebra (L6) as injection point, the spread of injectate and nerve staining was evaluated using gross anatomical dissection. PHASE II: sensory and motor blockade achieved with the GIN-CQLB or LSP blocks in Beagle dogs were evaluated and compared. The assigned technique was performed with 2% lidocaine: 0.2 mL kg-1 for the GIN and PS approaches and 0.3 mL kg-1 for the C-QLB and LPI approaches. RESULTS: Dissection revealed distribution of dye around the lumbar hypaxial musculature, extending into the paravertebral spaces, with staining of 3 (2-4) [median (interquartile range)] spinal nerves, spanning L3 to L6. The median motor blockade in the GIN-CQLB and LSP groups was 7 (7-8) versus 16 (10-16) (p = 0.026), whereas the median sensory blockade was 5 (4-5) versus 3 (3-3) (p = 0.025), respectively. CONCLUSION AND CLINICAL SIGNIFICANCE: The GIN-CQLB approach desensitized the thigh dermatomes effectively. Compared with the LSP approaches, GIN-CQLB exhibits a motor-protective effect by preserving tonic muscle function.

[COVID-19: Association of gasometric parameters at admission with in-hospital mortality]. / COVID-19: Parámetros gasométricos al ingreso y su asociación con mortalidad hospitalaria.

INTRODUCTION: At the beginning of the SARS-CoV-2 pandemic, acute respiratory failure has been the most important cause of hospitalization in patients with COVID-19, being more severe in patients with comorbidities and risk factors. In these scenarios hypoxemia has been associated with increased mortality. Our objective was to identify parameters obtained from arterial blood gases (ABG) associated with mortality in patients with COVID-19 at hospital admission. METHODS: GSA samples obtained by breathing room air (FiO2 21%) processed in the clinical laboratory were retrospectively studied in an ABL90 flex analyzer (Radiometer). RESULTS: Acute respiratory alkalosis was the predominant acid-base disturbance. Considering those patients with respiratory failure (paO2 < 60 mmHg), "silent" hypoxemia was observed in 11/176 (6%) of studied patients. In a multivariate analysis, three gasometric parameters at admission showed a positive association with hospital mortality: paO2 (p=0.053), paO2/pO2e index (which expresses the paO2 adjusted to the paO2 expected for age) (p=0.047) and fractional saturation of hemoglobin (OxiHb%) (p=0.028). DISCUSSION: GSA generate a key contribution in understanding the pathophysiology of the COVID-19 patient: in the initial evaluation, monitoring and prognosis of this disease.

Introducción: En los inicios de la pandemia por SARSCoV-2 la insuficiencia respiratoria aguda ha sido la causa más importante de hospitalización inmediata en los pacientes con COVID-19 que acudían a los servicios de urgencias, siendo mayor la gravedad en pacientes con comorbilidades y factores de riesgo preexistentes; en estos escenarios la hipoxemia ha sido asociada a mortalidad. Nuestro objetivo fue identificar parámetros obtenidos de los gases en sangre arterial (GSA) asociados a mortalidad en pacientes con COVID-19 al ingreso hospitalario. Métodos: Se estudiaron retrospectivamente muestras de GSA obtenidos respirando aire ambiente (FiO2 21%) procesadas en el laboratorio clínico en un analizador ABL90 flex (Radiometer). Resultados: La alcalosis respiratoria aguda fue el disturbio ácido base predominante. Considerando aquellos pacientes con insuficiencia respiratoria (paO2 < 60 mmHg) se observó hipoxemia "silenciosa" en 11/176 (6%) de los pacientes estudiados. En un análisis multivariado tres parámetros gasométricos al ingreso mostraron asociación positiva a mortalidad hospitalaria: paO2 (p = 0.053), índice paO2/pO2e (que expresa la paO2 ajustada a la paO2 esperada para la edad) (p = 0.047) y saturación fraccional de hemoglobina (OxiHb%) (p = 0.028). Discusión: Los GSA generan un aporte clave en la comprensión de la fisiopatología del paciente COVID-19; en la evaluación inicial, seguimiento y pronóstico de esta enfermedad.

Haemodynamic Effects of Pimobendan during General Anaesthesia in Healthy Senior Dogs: A Prospective, Randomised, Triple-Blinded, Placebo-Controlled Clinical Study.

Pimobendan is an inotropic and vasodilator drug with no sympathomimetic effects. This study aimed to evaluate the haemodynamic effects of pimobendan during anaesthesia in healthy senior dogs. A prospective, randomised, triple-blinded, placebo-controlled clinical study was conducted. Thirty-three dogs (median [range]: 9 [7, 12] years) were anaesthetised for surgical procedures. The dogs were randomly allocated into two groups: eighteen dogs received intravenous pimobendan at a dose of 0.15 mg/kg (PIMOBENDAN), and fifteen dogs received intravenous saline solutions at a dose of 0.2 mL/kg (PLACEBO). Data were recorded before, 1 min, 10 min, and 20 min after injection. Velocity-time integral (VTI), peak-velocity (PV), and mean-acceleration (MA) were measured using an oesophageal Doppler monitor (ODM). Heart rate and mean arterial pressure were also registered. The data were analysed using a two-way ANOVA for trimmed means. Statistical differences were considered if p < 0.05. Twenty minutes after injection, the VTI (13.0 cm [10.4, 22.3]), PV (95.0 [83.0, 160] m/s), and MA (12.6 [9.40, 17.0] m/s2) were significantly higher in the PIMOBENDAN group compared to the PLACEBO group (VTI: 10.5 [6.50, 17.4] cm, PV: 80.0 [62.0, 103] m/s and MA: 10.2 [7.00, 16.0] ms2). No significant differences were observed in the rest of the variables. Using pimobendan during anaesthesia increases VTI, PV, and MA, as measured by an ODM.

Echocardiographic indicators of fluid responsiveness in hospitalized dogs with compromised hemodynamics and tissue hypoperfusion.

OBJECTIVE: To evaluate the accuracy of selected echocardiographic variables used to predict fluid responsiveness in hospitalized dogs with compromised hemodynamics and tissue hypoperfusion. DESIGN: Diagnostic test study in a prospective cohort of hospitalized dogs. SETTING: Veterinary referral clinics. ANIMALS: Forty-four hospitalized dogs with compromised hemodynamics and tissue hypoperfusion were utilized in this study. INTERVENTIONS: Echocardiographic examination before and after fluid replacement with 30 ml/kg of lactated Ringer's solution. MEASUREMENTS AND MAIN RESULTS: Pre-fluid replacement measurements of velocity of transmitral E wave (E-peak), the left ventricular end-diastolic internal diameter normalized to body weight (LVIDdN), and the left ventricular end-systolic internal diameter normalized to body weight (LVIDsN) were significantly lower in fluid-responsive patients compared with nonresponders (P < 0.001). The area under the receiver operating characteristic curve (AUROC) with its 95% confidence interval (CI) for each significant predictor was as follows: E-peak 0.907 (0.776-1.000, P < 0.001) and LVIDdN 0.919 (0.801-1.000, P < 0.001). The predictive capacity of LVIDsN was not significantly better than chance (AUROC, 0.753; 95% CI, 0.472-1.000, P = 0.078). A significant negative linear correlation was observed between the percentage of increase in velocity-time integral after expansion and the echocardiographic variables LVIDdN (rs  = -0.452, P = 0.023) and E-peak (rs  = -0.396, P = 0.008) pre-fluid replacement. The intraobserver and interobserver variability was very low (<5 %) for all measurements. CONCLUSIONS: In this study using critically ill dogs with compromised hemodynamics and tissue hypoperfusion, pre-fluid replacement measurements of LVIDdN and E-peak adequately predict fluid responsiveness. Because a small number of fluid nonresponders were involved in the present study (11.4%), further studies that include larger numbers of fluid-nonresponsive animals are required.

Caudal vena cava measurements and fluid responsiveness in hospitalized cats with compromised hemodynamics and tissue hypoperfusion.

OBJECTIVE: To evaluate the use of the caudal vena cava collapsibility index (CVCCI) and the inspiratory/minimum and expiratory/maximum diameters of the vena cava to predict fluid responsiveness in hospitalized, critically ill cats with hemodynamic and tissue perfusion abnormalities. DESIGN: Diagnostic test study in a prospective cohort of hospitalized cats. SETTING: Private practice referral hospital. ANIMALS: Twenty-four hospitalized cats with spontaneous breathing and compromised hemodynamics and tissue hypoperfusion. INTERVENTIONS: Ultrasonographic examination before and after fluid expansion with 10 ml/kg of lactated Ringer's solution. MEASUREMENTS AND MAIN RESULTS: Fluid responsiveness was evaluated using the velocity-time integral (VTI) of the subaortic blood flow, by measuring it before and after a fluid load of 10 ml/kg of lactated Ringer's solution. The CVCCI was calculated using the following formula: (maximum diameter - minimum diameter / maximum diameter) × 100. Ten cats were fluid responders (42 %) and 14 were nonresponders (58 %). The area under the receiver operating characteristic curve (AUROC) with their 95% confidence interval for the predictors and the best cutoff values were as follows: CVCCI, AUROC = 0.83 (0.66-1.00) and cutoff = 31%; inspiratory/minimum diameter, AUROC = 0.86 (0.70-1.00) and cutoff = 0.24 cm; expiratory/maximum diameter, AUROC = 0.88 (0.74-1.00) and cutoff = 0.22 cm. A significant lineal correlation was observed between the percentage of increase in VTI after expansion and CVCCI (rs  = 0.68, P < 0.001), expiratory/maximum diameter (rs  = -0.72, P < 0.001), and inspiratory/minimum diameter (rs  = -0.71, P < 0.001). The intraobserver and interobserver variability was low for VTI, and the expiratory/maximum diameter and inspiratory/minimum diameter were high for CVCCI. CONCLUSIONS: Caudal vena cava measurements could be useful to predict the response to fluids in hospitalized cats with hemodynamic and tissue perfusion alterations. Additional studies are required to draw definitive conclusions about the role of these variables to guide fluid administration in cats.

Left-dominant arrhythmogenic cardiomyopathy in a Fila Brasileiro dog.

Background: In human medicine, arrhythmogenic left ventricular cardiomyopathy was described as a primary disease of the heart characterized by fibroadipose replacement of the myocardium.. Case Description: We report the case of a dog, with history of syncope and irregular cardiac rhythm. Electrocardiogram, echocardiography, and a 24-hour Holter monitoring showed, respectively, the presence of premature ventricular complexes with right bundle branch block morphology, an increase of the left ventricle end-diastolic diameter with preserved fractional shortening and ejection fraction, and a sinus arrhythmia as baseline rhythm with supraventricular tachycardia episodes and ventricular complexes with left bundle branch block morphology. After the death of the canine, a postmortem examination showed cardiomegaly. Fibroadipose replacement of the septum and both ventricles, with left ventricle myocardial fibrosis, suggestive of previous necrosis, was observed. Conclusion: These findings are suggestive of left-dominant arrhythmogenic cardiomyopathy which, to the best of our knowledge, has not been described in veterinary medicine.

Lung aeration and volumes following alveolar recruitment maneuvers with three airway pressures in healthy anesthetized and mechanically ventilated Beagle dogs.

OBJECTIVE: To compare the effects of three recruitment airway pressures (RPaw) on lung aeration and volumes in mechanically ventilated dogs during propofol anesthesia. STUDY DESIGN: Prospective, crossover randomized experimental study. ANIMALS: A total of eight healthy anesthetized experimental Beagle dogs in dorsal recumbency. METHODS: Dogs were mechanically ventilated with a tidal volume of 15 mL kg-1 and zero positive end-expiratory pressure and 100% oxygen. Three maneuvers consisting of a 30 second inspiration at RPaws of 15 (RPaw15), 25 (RPaw25) and 35 (RPaw35) cmH2O were performed randomly, 15 minutes apart. Changes in lung aeration and lung deformation were compared with end-expiratory baseline (before the application of each RPaw) and between-RPaws using computed tomography scans and calculations of global lung strain. Between-group comparisons were performed with one-way anova for repeated measures followed by Tukey test for multiple comparisons. A p value < 0.05 was considered significant. RESULTS: The amount of nonaeration was minimal (<1%) at baseline and not different with the application of the RPaws. The amount of hypoaeration and normoaeration during baseline decreased with all RPaws (p < 0.001). There was no difference between RPaws regarding hypoaeration (all p > 0.999), whereas normoaeration was higher at RPaw15 than RPaw25 and RPaw35 (p < 0.009). Compared with baseline, the fraction of hyperaerated alveoli increased with each RPaw (p < 0.001) and was lower during RPaw15 than RPaw25 and RPaw35 (both p ≤ 0.007). Global lung strain was lower during RPaw15 than at higher RPaw (p < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE: A RPaw of 15 cmH2O for 30 seconds was the recommended RPaw because it was as effective at reversing hypoaeration as RPaws of 25 and 35 cmH2O but with less hyperaeration and potential for overdistension of the lungs in this particular population of dogs with negligible atelectasis.

Retrospective evaluation of jugular venous blood variables and mortality in critically ill hospitalized cats.

OBJECTIVE: To evaluate clinicopathological variables associated with hospital mortality in critically ill cats with compromised hemodynamics and tissue hypoperfusion. DESIGN: Retrospective observational study. SETTING: Private referral center. ANIMALS: Fifty-seven critically ill cats with compromised hemodynamics or tissue hypoperfusion. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The electronic medical records were searched for all cats admitted from June 2014 to November 2020. Cats were included in the study if the medical records clearly identified the presence of compromised hemodynamics and tissue hypoperfusion. Blood samples were obtained by percutaneous puncture of the external jugular vein, and blood gases, electrolytes, L-lactate concentration, and glucose were measured by a point-of-care analyzer. A predictive logistic regression model for mortality was performed. A total of 57 cats were ultimately included in the study. Thirty-five cats died. Eighteen of them were euthanized because of the severity of illness, and 17 died naturally. Twenty-two cats were discharged alive from the hospital. After adjusting for the Acute Patient Physiologic and Laboratory Evaluation (APPLE) fast score and disease category, jugular venous partial pressure of oxygen (Pvjo2 ) and HCT at admission were independent predictors of hospital mortality (HCT: odds ratio [OR], 0.763, 95% confidence interval [CI]: 0.625-0.930; P = 0.008; Pjvo2 : OR, 0.858; 95% CI: 0.749-0.984; P = 0.029). The association of these variables with mortality was maintained after conducting a sensitivity analysis and excluding cats that died by euthanasia. CONCLUSIONS: In cats with hemodynamic instability and tissue hypoperfusion, HCT and Pvjo2 behaved as independent predictors of mortality. Both variables seem to reflect the magnitude of oxygen debt and tissue hypoperfusion.

Agreement between transthoracic echocardiography and esophageal Doppler on aortic flow variables in anesthetized mechanically ventilated dogs.

The use of transthoracic echocardiography (TTE) and esophageal Doppler (ED) for the measurement of hemodynamic variables in anesthetized dogs was studied. Fourteen mixed-breed dogs, without cardiac disease, undergoing general anesthesia for diagnostic or therapeutic procedures were included in this prospective preliminary study. Dogs were premedicated with dexmedetomidine (3 µg/kg) and methadone (0.3 mg/kg), intramuscularly. General anesthesia was induced with propofol intravenously titrated to effect and maintained with isoflurane in oxygen. Animals were positioned in dorsal recumbency. Transthoracic echocardiography was performed using a 5-2 MHz cardiac ultrasound probe placed in the subcostal window, whereas esophageal Doppler was performed using a CardioQ probe (MP50; Deltex Medical, Chichester, UK). Once an appropriate view of the aortic flow was obtained, the variables peak velocity (PV) and velocity-time integral (VTI) were measured. Agreement between methods was evaluated using the Bland-Altman method with single observation per individual. The bias and the limits of agreement (LOA) between the two methods were determined. Mean (± SD) PV was 99.46 cm/s (± 42.73 cm/s) and 110.29 cm/s (± 35.86 cm/s), and VTI was 13.24 cm (± 4.33 cm) and 13.05 cm (± 4.47 cm), for TTE and ED, respectively. Mean differences and LOA were 10.83 cm/s (range: -20.50 to 42.16 cm/s) and -0.19 cm (range: -3.32 to 2.95 cm) for PV and VTI, respectively. No statistically significant differences were determined in the variables measured between TTE and ED in anesthetized dogs without cardiac disease, positioned in dorsal recumbency. This could be of clinical relevance when an evaluation of the intraoperative hemodynamic status of anesthetized dogs is desired.

Concordance entre l'échocardiographie transthoracique et le Doppler oesophagien sur les variables du débit aortique chez des chiens anesthésiés ventilés mécaniquement. L'utilisation de l'échocardiographie transthoracique (TTE) et du Doppler oesophagien (ED) pour la mesure des variables hémodynamiques chez les chiens anesthésiés a été étudiée. Quatorze chiens de race mixte, sans maladie cardiaque, subissant une anesthésie générale pour des procédures diagnostiques ou thérapeutiques ont été inclus dans cette étude préliminaire prospective. Les chiens ont reçu une prémédication avec de la dexmédétomidine (3 µg/kg) et de la méthadone (0,3 mg/kg), par voie intramusculaire. L'anesthésie générale a été induite avec du propofol intraveineux titré à effet et maintenue avec de l'isoflurane dans de l'oxygène. Les animaux ont été placés en décubitus dorsal. L'échocardiographie transthoracique a été réalisée à l'aide d'une sonde à ultrasons cardiaque 5-2 MHz placée dans la fenêtre sous-costale, tandis que le Doppler oesophagien a été réalisé à l'aide d'une sonde CardioQ (MP50; Deltex Medical, Chichester, Royaume-Uni). Une fois qu'une vue appropriée de l'aorte était obtenue, les variables vitesse maximale (PV) et intégrale vitesse-temps (VTI) étaient mesurées. La concordance entre les méthodes a été évaluée à l'aide de la méthode de Bland-Altman avec une seule observation par individu. Le biais et les limites d'accord (LOA) entre les deux méthodes ont été déterminés. La PV moyenne (± SD) était de 99,46 cm/s (± 42,73 cm/s) et 110,29 cm/s (± 35,86 cm/s), et la VTI était de 13,24 cm (± 4,33 cm) et 13,05 cm (± 4,47 cm), pour TTE et ED, respectivement. Les différences moyennes et la LOA étaient de 10,83 cm/s (intervalle : −20,50 à 42,16 cm/s) et de −0,19 cm (intervalle : −3,32 à 2,95 cm) pour PV et VTI, respectivement. Aucune différence statistiquement significative n'a été déterminée dans les variables mesurées entre TTE et ED chez des chiens anesthésiés sans maladie cardiaque, positionnés en décubitus dorsal. Cela pourrait être cliniquement pertinent lorsqu'une évaluation de l'état hémodynamique peropératoire des chiens anesthésiés est souhaitée.(Traduit par Dr Serge Messier).

Ecografía pulmonar como predictor de terapia intensiva en neumonía por COVID-19 / Lung ultrasound as predictor of intensive therapy in COVID-19 pneumonia

Resumen La ecografía pulmonar (EP) ha demostrado ser una herramienta útil para detectar el grado de compromiso pulmonar en neumonía y síndrome de distrés respiratorio agudo. El presente estudio evalúa la asociación entre la puntuación de EP de 12 regiones y el ingreso de terapia intermedia a terapia intensiva en pacientes con neumonía por COVID-19. Se incluyó un total de 115 pacientes con diagnóstico de neumonía confirmada por radiografía de tórax, por SARS-CoV-2, se realizó una EP junto con la evaluación de laboratorio que incluyó la medición de marcadores inflamatorios (linfocitos, proteína C reactiva, Dímero D, procalcitonina, ferritina, lactato deshidrogenasa y pro péptido natriurético de tipo B). Se utilizó una puntuación ecográfica pul monar que caracteriza el grado de afección pulmonar como leve, moderado y grave, y se comparó el resultado con los marcadores inflamatorios de laboratorio. En el análisis univariado se observó una asociación entre la puntuación de la EP, los niveles elevados de procalcitonina y péptido natriurético cerebral y el ingreso a terapia intensiva. En el análisis multivariado solo la puntuación de EP fue un predictor independiente de requerimiento de terapia intensiva.

Abstract Lung ultrasound (LUS) has shown to be a useful tool to detect the degree of pulmonary involvement in patients with pneumonia and acute respiratory distress syndrome. The present study evaluates the association of the 12-region lung ultrasound score and the requirements of intensive care unit, in patients with COVID-19 infection who were admitted to intermediate care in a specialized hospital; 115 patients with a diagnosis of pneumonia confirmed by chest radiography secondary to SARS-CoV-2 were included, LUS was performed together with the laboratory evaluation that included the measurement of inflammatory biomarkers (lymphocytes, C-reactive protein, D-dimer, procalcitonin, ferritin, lactate dehydrogenase, and pro B-type natriuretic peptide). Lung ultrasound score was used, characterizing the degree of lung involvement as mild, moderate, and severe, and the results were compared with inflammatory biomarkers. In the univariate analysis, an association was observed between the lung ultrasound score, elevated levels of procalcitonin and brain natriuretic peptide, and the admission to intensive care. In the multivariate analysis, only the lung ultrasound score was an independent predictor of need for intensive therapy.

[Lung ultrasound as predictor of intensive therapy in COVID-19 pneumonia]. / Ecografía pulmonar como predictor de terapia intensiva en neumonía por COVID-19.

Lung ultrasound (LUS) has shown to be a useful tool to detect the degree of pulmonary involvement in patients with pneumonia and acute respiratory distress syndrome. The present study evaluates the association of the 12-region lung ultrasound score and the requirements of intensive care unit, in patients with COVID-19 infection who were admitted to intermediate care in a specialized hospital; 115 patients with a diagnosis of pneumonia confirmed by chest radiography secondary to SARS-CoV-2 were included, LUS was performed together with the laboratory evaluation that included the measurement of inflammatory biomarkers (lymphocytes, C-reactive protein, D-dimer, procalcitonin, ferritin, lactate dehydrogenase, and pro B-type natriuretic peptide). Lung ultrasound score was used, characterizing the degree of lung involvement as mild, moderate, and severe, and the results were compared with inflammatory biomarkers. In the univariate analysis, an association was observed between the lung ultrasound score, elevated levels of procalcitonin and brain natriuretic peptide, and the admission to intensive care. In the multivariate analysis, only the lung ultrasound score was an independent predictor of need for intensive therapy.

La ecografía pulmonar (EP) ha demostrado ser una herramienta útil para detectar el grado de compromiso pulmonar en neumonía y síndrome de distrés respiratorio agudo. El presente estudio evalúa la asociación entre la puntuación de EP de 12 regiones y el ingreso de terapia intermedia a terapia intensiva en pacientes con neumonía por COVID-19. Se incluyó un total de 115 pacientes con diagnóstico de neumonía confirmada por radiografía de tórax, por SARS-CoV-2, se realizó una EP junto con la evaluación de laboratorio que incluyó la medición de marcadores inflamatorios (linfocitos, proteína C reactiva, Dímero D, procalcitonina, ferritina, lactato deshidrogenasa y pro péptido natriurético de tipo B). Se utilizó una puntuación ecográfica pulmonar que caracteriza el grado de afección pulmonar como leve, moderado y grave, y se comparó el resultado con los marcadores inflamatorios de laboratorio. En el análisis univariado se observó una asociación entre la puntuación de la EP, los niveles elevados de procalcitonina y péptido natriurético cerebral y el ingreso a terapia intensiva. En el análisis multivariado solo la puntuación de EP fue un predictor independiente de requerimiento de terapia intensiva.

Distribution and Magnitude of Regional Volumetric Lung Strain and Its Modification by PEEP in Healthy Anesthetized and Mechanically Ventilated Dogs.

The present study describes the magnitude and spatial distribution of lung strain in healthy anesthetized, mechanically ventilated dogs with and without positive end-expiratory pressure (PEEP). Total lung strain (LSTOTAL) has a dynamic (LSDYNAMIC) and a static (LSSTATIC) component. Due to lung heterogeneity, global lung strain may not accurately represent regional total tissue lung strain (TSTOTAL), which may also be described by a regional dynamic (TSDYNAMIC) and static (TSSTATIC) component. Six healthy anesthetized beagles (12.4 ± 1.4 kg body weight) were placed in dorsal recumbency and ventilated with a tidal volume of 15 ml/kg, respiratory rate of 15 bpm, and zero end-expiratory pressure (ZEEP). Respiratory system mechanics and full thoracic end-expiratory and end-inspiratory CT scan images were obtained at ZEEP. Thereafter, a PEEP of 5 cmH2O was set and respiratory system mechanics measurements and end-expiratory and end-inspiratory images were repeated. Computed lung volumes from CT scans were used to evaluate the global LSTOTAL, LSDYNAMIC, and LSSTATIC during PEEP. During ZEEP, LSSTATIC was assumed zero; therefore, LSTOTAL was the same as LSDYNAMIC. Image segmentation was applied to CT images to obtain maps of regional TSTOTAL, TSDYNAMIC, and TSSTATIC during PEEP, and TSDYNAMIC during ZEEP. Compliance increased (p = 0.013) and driving pressure decreased (p = 0.043) during PEEP. PEEP increased the end-expiratory lung volume (p < 0.001) and significantly reduced global LSDYNAMIC (33.4 ± 6.4% during ZEEP, 24.0 ± 4.6% during PEEP, p = 0.032). LSSTATIC by PEEP was larger than the reduction in LSDYNAMIC; therefore, LSTOTAL at PEEP was larger than LSDYNAMIC at ZEEP (p = 0.005). There was marked topographic heterogeneity of regional strains. PEEP induced a significant reduction in TSDYNAMIC in all lung regions (p < 0.05). Similar to global findings, PEEP-induced TSSTATIC was larger than the reduction in TSDYNAMIC; therefore, PEEP-induced TSTOTAL was larger than TSDYNAMIC at ZEEP. In conclusion, PEEP reduced both global and regional estimates of dynamic strain, but induced a large static strain. Given that lung injury has been mostly associated with tidal deformation, limiting dynamic strain may be an important clinical target in healthy and diseased lungs, but this requires further study.

Retrospective evaluation of the use of quick Sepsis-related Organ Failure Assessment (qSOFA) as predictor of mortality and length of hospitalization in dogs with pyometra (2013-2019): 52 cases.

OBJECTIVE: To evaluate the prognostic utility of quick Sepsis-related Organ Failure Assessment (qSOFA) for prediction of in-hospital mortality and length of hospitalization in dogs with pyometra. DESIGN: Retrospective cohort study from February 2013 to April 2019 SETTING: Tertiary referral hospital ANIMALS: Fifty-two dogs referred with confirmed diagnosis of pyometra INTERVENTIONS: None MEASUREMENTS AND PRINCIPAL OUTCOMES: Sixty-five percent of dogs survived to discharge. A cut-off score of ≥2 for qSOFA was associated with in-hospital mortality (odds ratio 6.51 [95% CI: 1.35 - 31.3]) P = 0.019. The area under the receiver operator characteristic curve for a qSOFA score ≥ 2 for mortality was 0.72 (95% CI: 0.59-0.85), with a sensitivity of 77.8% and a specificity of 66.7%. The mean ± SD number of organs with dysfunction was significantly higher in dogs with a qSOFA score ≥2 1.76 ± 0.83 compared to dogs with a qSOFA score < 2 1.08 ± 1.09, P = 0.015. The presence of a qSOFA score ≥ 2 was associated with a longer time of hospitalization in survivors with a median (interquartile range) length of stay in qSOFA < 2 (48 [33]) hours versus qSOFA score ≥ 2 (78 [52]) hours, P = 0.027. CONCLUSIONS: In dogs with pyometra, the qSOFA score was associated with mortality and length of hospitalization. This score might be useful to improve the risk stratification in dogs with pyometra. Further studies are necessary to evaluate the predictive capacity of qSOFA in other septic patient populations.

Respuesta humoral y persistencia de anticuerpos anti-SARS-CoV-2 en pacientes hospitalizados / SARS-CoV-2 antibodies kinetics in hospitalized patients

Resumen Luego de la infección por SARS-CoV-2 se producen anticuerpos específicos y continúa siendo objeto de estudio su cinética, cuantificación y umbral protector. Nuestro objetivo fue estudiar la cinética de aparición de anticuerpos IgG/IgM anti SARS-CoV-2, magnitud de respuesta y duración en el tiempo, en 55 pacientes hospitalizados por COVID-19, y relacionar el patrón de respuesta con diferentes parámetros demográ ficos y clínicos. Medidas con un ensayo cualitativo automatizado, VIDAS® SARS-Cov-2 (Biomerieux - ELFA) se evaluaron las variaciones en la concentración de anticuerpos a lo largo del tiempo con un modelo generalizado de efectos fijos. Todos los pacientes seroconvirtieron IgM e IgG, al día 10 y 10.5 respectivamente, patrón sincrónico mayoritario; no siendo de utilidad la IgM aislada como indicador de respuesta aguda. La sensibilidad clínica fue: semana 1, 30%, semanas 2 y 3, 72%, 4: 91% y 8: 96%. IgG permaneció detectable hasta los 6 meses (período de seguimiento) con gran heterogeneidad de magnitud; IgM negativizó en el 90.9% de los pacientes. Observamos un nivel mayor de IgM en los pacientes > 56 años, y en hombres respecto a mujeres. En pacientes con enfer medad pulmonar obstructiva crónica la respuesta de IgM está aumentada; los inmunocomprometidos y aquellos con enfermedad pulmonar intersticial difusa tuvieron menor IgM e IgG respectivamente. De nuestro grupo de pacientes, aquellos que requirieron cuidados críticos, asistencia respiratoria mecánica y los que fallecieron no presentaron diferencias significativas en magnitud de respuesta humoral respecto de quienes tuvieron un curso menos grave. La metodología utilizada refleja adecuadamente la cinética de anticuerpos.

Abstract Specific antibodies are produced after infection by SARS-CoV2. Currently, the understanding of antibody responses following infection with SARS-CoV-2 is limited including the magnitude, duration of responses and correlates of protective immunity following infection. Here we intended to characterize humoral immune response in a cohort of 55 hospitalized patients for COVID-19 and its relationship with different demographic and clinical parameters. The ELFA assay VIDAS® SARS-Cov-2 (Biomerieux) measured IgG/IgM antibodies. Their concentration over time was evaluated with a fixed effects generalized linear model. All patients seroconverted IgM and IgG, at day 10 and 10.5 respectively, showing a majority synchronous pattern; IgM alone would not be useful as a marker of acute response. Clini cal sensitivity was: week 1, 30%, weeks 2 and 3, 72%, 4: 91% and 8: 96%. IgG seropositivity was sustained in patients up to 180 days (last time point measured), in contrast, IgM response was short-lived (91days) in 90.9% of patients. Longer term follow-up is needed to determine the duration of IgG responses. We observed a higher level of IgM in patients > 56 years, and in men compared to women. In chronic obstructive pulmonary disease patients, the IgM response is increased, while in immunocompromised and interstitial lung disease patients, IgM and IgG were lower, respectively. Those patients who required critical care, mechanical ventilation and those who died did not present significant differences in the magnitude of humoral response compared to those who had a less severe course. The methodology used adequately reflects the kinetics of antibodies.

[SARS-CoV-2 antibodies kinetics in hospitalized patients]. / Respuesta humoral y persistencia de anticuerpos anti-SARS-CoV-2 en pacientes hospitalizados.

Specific antibodies are produced after infection by SARS-CoV2. Currently, the understanding of antibody responses following infection with SARS-CoV-2 is limited including the magnitude, duration of responses and correlates of protective immunity following infection. Here we intended to characterize humoral immune response in a cohort of 55 hospitalized patients for COVID-19 and its relationship with different demographic and clinical parameters. The ELFA assay VIDAS® SARS-Cov-2 (Biomerieux) measured IgG/IgM antibodies. Their concentration over time was evaluated with a fixed effects generalized linear model. All patients seroconverted IgM and IgG, at day 10 and 10.5 respectively, showing a majority synchronous pattern; IgM alone would not be useful as a marker of acute response. Clinical sensitivity was: week 1, 30%, weeks 2 and 3, 72%, 4: 91% and 8: 96%. IgG seropositivity was sustained in patients up to 180 days (last time point measured), in contrast, IgM response was short-lived (91days) in 90.9% of patients. Longer term follow-up is needed to determine the duration of IgG responses. We observed a higher level of IgM in patients > 56 years, and in men compared to women. In chronic obstructive pulmonary disease patients, the IgM response is increased, while in immunocompromised and interstitial lung disease patients, IgM and IgG were lower, respectively. Those patients who required critical care, mechanical ventilation and those who died did not present significant differences in the magnitude of humoral response compared to those who had a less severe course. The methodology used adequately reflects the kinetics of antibodies.

Luego de la infección por SARS-CoV-2 se producen anticuerpos específicos y continúa siendo objeto de estudio su cinética, cuantificación y umbral protector. Nuestro objetivo fue estudiar la cinética de aparición de anticuerpos IgG/IgM anti SARS-CoV-2, magnitud de respuesta y duración en el tiempo, en 55 pacientes hospitalizados por COVID-19, y relacionar el patrón de respuesta con diferentes parámetros demográficos y clínicos. Medidas con un ensayo cualitativo automatizado, VIDAS® SARS-Cov-2 (Biomerieux - ELFA) se evaluaron las variaciones en la concentración de anticuerpos a lo largo del tiempo con un modelo generalizado de efectos fijos. Todos los pacientes seroconvirtieron IgM e IgG, al día 10 y 10.5 respectivamente, patrón sincrónico mayoritario; no siendo de utilidad la IgM aislada como indicador de respuesta aguda. La sensibilidad clínica fue: semana 1, 30%, semanas 2 y 3, 72%, 4: 91% y 8: 96%. IgG permaneció detectable hasta los 6 meses (período de seguimiento) con gran heterogeneidad de magnitud; IgM negativizó en el 90.9% de los pacientes. Observamos un nivel mayor de IgM en los pacientes > 56 años, y en hombres respecto a mujeres. En pacientes con enfermedad pulmonar obstructiva crónica la respuesta de IgM está aumentada; los inmunocomprometidos y aquellos con enfermedad pulmonar intersticial difusa tuvieron menor IgM e IgG respectivamente. De nuestro grupo de pacientes, aquellos que requirieron cuidados críticos, asistencia respiratoria mecánica y los que fallecieron no presentaron diferencias significativas en magnitud de respuesta humoral respecto de quienes tuvieron un curso menos grave. La metodología utilizada refleja adecuadamente la cinética de anticuerpos.

Findings suggestive of coronary microvascular dysfunction in cats with myocardial ischemia.

Background: Myocardial infarction (MI) is an important cause of death and disability among humans worldwide. Few studies have reported the occurrence of MI in small animals as well. Reports in human medicine indicate that up to 30% of patients with clinical signs compatible with myocardial ischemia suggestive of coronary disease exhibit normal epicardial arteries at angiography. These symptoms have been associated with a syndrome characterized by alterations in cardiac microvasculature, known as coronary microvascular dysfunction (CMD). Aim: This study aimed to describe the necropsy findings and clinical-pathological characterization (when available) of cats with histopathological findings suggesting CMD. Methods: Necropsy records of cats presenting histopathological diagnosis compatible with acute and/or chronic MI, with normal epicardial arteries and microvascular disorders were evaluated. Results: Twenty animals met the inclusion criteria. Eight cats (40%) exhibited findings compatible with mild hypertrophic cardiomyopathy (HCM) without left atrial enlargement, one (5%) presented restrictive cardiomyopathy, and another one (5%) had lesions consistent with histiocytoid cardiomyopathy. The remaining cats (50%) showed alterations compatible with severe HCM with left atrial enlargement. In all cases, epicardial arteries were normal (without obstruction). All the evaluated hearts exhibited myocardial multifocal fibrosis along with replacement of cardiomyocytes by adipose tissue and blood vessels with hyperplasia and hypertrophy of the muscular layer with protrusion of the nuclei of the endothelial cells. Conclusion: These findings suggest the presence of microvascular dysplasia of the coronary arteries. Further studies are necessary to confirm and clinically characterize these results.

Development of highly sensitive one step-PCR tests for improved detection of B. bigemina and B. bovis.

Bovine babesiosis caused by Babesia bigemina and B. bovis is an economically relevant tick-borne disease distributed over tropical and subtropical world regions. Animals that recover from the clinical disease can remain persistently infected, and those carriers are epidemiologically relevant since they can act as a source of infection to other animals through the tick bite. According to the manual of the World Organisation for Animal Health (OIE), the recommended molecular diagnosis test for both parasites is a nested polymerase chain reaction (nPCR) based on an amplification of a fragment of the rap-1 gene. Since nPCRs are time consuming, have a higher cost and risk of contamination, we propose a single step PCR for B. bigemina (BbiVESA) and B. bovis (BboVESA) based on the amplification of the multi-copy ves-1α gene. We developed these methods and we achieved a detection limit of 1 × 10-12 % parasitemia for B. bigemina and of 1 × 10-6 % for B. bovis using reference strains, which compared to the reference OIE tests, results in an improvement in sensitivity of six orders for B. bigemina. Finally, we tested 48 field samples from a babesiosis enzootic region where we were able to detect a higher proportion of positive animals with both VESA methods than with the reference rap-1 nPCRs. This difference was statistically significant for each Babesia species. Concordance between both diagnostic schemes based on Cohen's kappa coefficient showed minimal to non-agreement (κ = 0.32) for B. bigemina and non-agreement (κ = 0.16) for B. bovis since BbiVESA and BboVESA PCR tests showed a significantly higher detection capacity. In conclusion, the high sensitivity of the assay, together with the lower demand of time and reagents make the VESA PCR methods developed here a valuable diagnostic tool for the molecular detection and epidemiological survey of both Babesia pathogens.

Efficacy of tramadol for postoperative pain management in dogs: systematic review and meta-analysis.

OBJECTIVE: To evaluate the evidence of analgesic efficacy of tramadol for the management of postoperative pain and the presence of associated adverse events in dogs. DATABASES USED: A comprehensive search using PubMed/MEDLINE, LILACS, Google Scholar and CAB databases with no restrictions on language and following a prespecified protocol was performed from June 2019 to July 2020. Included were randomized controlled trials (RCTs) performed in dogs that had undergone general anesthesia for any type of surgery. Two authors independently classified the studies, extracted data and assessed their risk of bias using Cochrane's tool. RevMan and GRADE methods were used to rate the certainty of evidence (CoE). CONCLUSIONS: Overall 26 RCTs involving 848 dogs were included. Tramadol administration probably results in a lower need for rescue analgesia versus no treatment or placebo [moderate CoE; relative risk (RR): 0.47; 95% confidence interval (CI): 0.26-0.85; I2 = 0%], and may result in a lower need for rescue analgesia versus buprenorphine (low CoE; RR: 0.50; 95% CI: 0.20-1.24), codeine (low CoE; RR: 0.75; 95% CI: 0.16-3.41) and nalbuphine (low CoE; RR: 0.05; 95% CI: 0.00-0.72). However, tramadol administration may result in an increased requirement for rescue analgesia versus methadone (low CoE; RR: 3.45; 95% CI: 0.66-18.08; I2 = 43%) and COX inhibitors (low CoE; RR: 2.27; 95% CI: 0.68-7.60; I2 = 45%). Compared with multimodal therapy, tramadol administration may make minimal to no difference in the requirement for rescue analgesia (low CoE; RR: 1.12; 95% CI: 0.48-2.60; I2 = 0%). Adverse events were inconsistently reported and the CoE was very low. The overall CoE of the analgesic efficacy of tramadol for postoperative pain management in dogs was low or very low, and the main reasons for downgrading the evidence were risk of bias and imprecision.

Successful resolution of urothorax secondary to non-traumatic uroabdomen in a cat managed with peritoneal dialysis as a bridge to surgery.

CASE SUMMARY: A 9-year-old neutered male domestic shorthair cat was presented for evaluation of severe hemodynamic collapse and suspected lower urinary tract disease. On admission, severe metabolic acidosis, hyperkalemia and azotemia, and electrocardiographic findings consistent with cardiotoxicity were identified. The diagnosis of uroabdomen was made based on abdominal fluid to plasma concentration ratios of creatinine and potassium. A central line catheter was placed percutaneously into the abdomen for peritoneal drainage and used for peritoneal dialysis as a bridge to surgery. Retrograde contrast cystography confirmed rupture of the urinary bladder. Point-of-care ultrasound of the chest postoperatively revealed the presence of mild pleural effusion. Echocardiography was then performed showing no evidence of cardiac disease. Pleural fluid analysis revealed a transudate with a creatinine ratio of 2.38 ([Creatinine]pleural fluid/[Creatinine]plasma), consistent with the diagnosis of urothorax. The cat recovered uneventfully from surgery and was monitored for signs of respiratory distress during the rest of its stay in hospital. The cat was discharged 4 days later and the pleural effusion resolved without further medical intervention. RELEVANCE AND NOVEL INFORMATION: There is limited information on the causes of urothorax and uroabdomen management of feline patients. Pleural effusion is a complication observed in critically ill cats secondary to fluid overload, underlying cardiomyopathy, primary thoracic pathology or a combination of these. To our knowledge, this is the first report of urothorax in a cat secondary to non-traumatic uroabdomen. Careful monitoring of respiratory signs consistent with pleural space disease is recommended in cases of uroabdomen.